Psychosocial Oncology
Up to half of all cancer patients experience clinical relevant distress while a third of all individuals suffer from a comorbid mental and behavioral disorder. Quality of Life could decline over the treatment-course and several essential questions might occur throughout the disease.
Psychooncology provides non-pharmacological interventions in order to faciliate mental well-being and provide support throughout all stages of the respective disease.
Clinican scientists of the Psychooncological Service not only provide support in clinical routine. Additionally, we contribute in national and international scientific efforts to improve our patients psychological well-being.
Research Focus
the research of the psychooncological team focusses on
- Improving Quality of Life of cancer patients and their families. We aim to develop valid, patient-reported measurement tools to incorporate the patients‘ voices into cancer care and research.
- Investigating predictors for unplanned readmissions in outpatients by determining informal care-givers psychological burden as well as structural parameters.
- Providing tailored, supportive interventions focussing on the improvement of psychological outcomes and Quality of Life in cancer patients.
We are closely collaborating with the „NCT/UCC Core Unit: Outcome and health-services research“ (Dr. M. Eichler) and regularly contributing in national (e.g. S3-guideline „Psychooncology“ and „Soft Tissue Sarcoma“) and international studies and projects (EORTC).
Selected projects – Selection of Ongoing Studies:
- PrePP (Prediction Readmission in Palliative Patients): Identifying risk factors for unplanned readmission in specialized outpatient palliative care; further information: https://clinicaltrials.gov/ct2/show/NCT05082389?term=PRePP&draw=2&rank=2
- OPTI-Screen (DKH-funded): Optimized psycho-oncology care through an interdisciplinary care algorithm - from screening to intervention
- OPUS: implementation and feasibility of an online support programme for patients under radiotherapy
- LUPE (DKH-funded): longitudinal analysis of psycho-oncological care needs of cancer patients and their relatives
- PRO-CTCAE-questionnaires: developing and validating patient-reported item-sets to report adverse events in different cancer entities
- EORTC questionnaires: developing and validating patient-reported questionnaires to assess Quality of Life
Closed Projects – Selection of Closed Studies:
- YonLife: providing tailored treatment recommendations in supportive sarcoma care
- Corona and Cancer (WIBCE): Assessment of psychological distress, care situation as well as quality of life of cancer patients at the beginning of the COVID19 pandemic
A more detailed description of current projects can be derived here in German.
2025
Ernst J, Köditz AK, Goerling U, Zimmermann T, Hornemann B, Springer F, Mehnert-Theuerkauf A.
Perceived stigmatization in cancer patients during the first year after diagnosis: the role of socioeconomic status. J Cancer Surviv. 2025 May 26. doi: 10.1007/s11764-025-01834-0. Epub ahead of print. PMID: 40419833.
Köditz AK, Mehnert-Theuerkauf A, Goerling U, Zimmermann T, Hornemann B, Springer F, Friedrich M, Ernst J.
Dyadic coping after cancer diagnosis – a longitudinal cluster analysis. Acta Oncol. 2025 Mar 18;64:431-438. doi: 10.2340/1651-226X.2025.42561. PMID: 40100029; PMCID: PMC11934276.
Haering C, Heyne S, Mehnert-Theuerkauf A, Hornemann B, Dreismann L, Ginger V, Zimmermann T.
The role of patient activation in mediating the effects of health literacy level on quality of life among patients with gastrointestinal cancers. Sci Rep. 2025 Mar 1;15(1):7295. doi: 10.1038/s41598-025-91670-0. PMID: 40025154; PMCID: PMC11873287.
Zingler H, Steinmann D, Ernst J, Goerling U, Hermann M, Hornemann B, Mehnert-Theuerkauf A, Zimmermann T.
Psychosocial distress, perceived need and utilization of psycho- social support services in patients in the early phase after the first cancer diagnosis. J Cancer Res Clin Oncol. 2025 Feb 6;151(2):65. doi: 10.1007/s00432-025-06107-y. PMID: 39912968; PMCID: PMC11802609.
Salm H, Schuler MK, Hentschel L, Richter S, Hohenberger P, Kasper B, Andreou D, Pink D, Mütze L, Arndt K, Hofbauer C, Schaser KD, Weitz J, Schmitt J, Eichler M.
Preferences on Treatment Decision Making in Sarcoma Patients: Prevalence and Associated Factors - Results from the PROSa Study. Oncol Res Treat. 2025;48(4):174-185. doi: 10.1159/000543456. Epub 2025 Jan 15. PMID: 39814000.
Springer F, Goerling U, Zimmermann T, Ernst J, Engel C, Hermann M, Esser P, Hornemann B, Keilholz U, Lordick F, Knesebeck OVD, Kissane D, Mehnert-Theuerkauf A.
Course of Mental Disorders in Early Cancer Survivorship in Relation to Socioeconomic Status: A Multi-Center Prospective Longitudinal Study (LUPE). Psychooncology. 2025 Jan;34(1):e70059. doi: 10.1002/pon.70059. PMID: 39780021; PMCID: PMC11711303.
2024
Hermann M, Goerling U, Hearing C, Mehnert-Theuerkauf A, Hornemann B, Hövel P, Reinicke S, Zingler H, Zimmermann T, Ernst J.
Social Support, Depression and Anxiety in Cancer Patient-Relative Dyads in Early Survivorship: An Actor-Partner Interdependence Modeling Approach. Psychooncology. 2024 Dec;33(12):e70038. doi: 10.1002/pon.70038.
Eichler M, Hentschel L, Hornemann B, Schuler M, Richter S, Meier F, Weitz J, Schaser KD, Krause M, Mütherig A, Thomas T, Weigmann-Faßbender S, Schmädig R, Rentsch A, Vetter H, Kemmerer M, Ehninger G, Eberlein-Gonska M, Schmitt J, Bornhäuser M, Hofbauer C.
Erfahrungen und Ergebnisse bei der Integration von ePROs in die Routineversorgung eines onkologischen Spitzenzentrums: eine Analyse mithilfe des CFIR [ePROs in the routine care of a major oncology center: Results and experiences]. Z Evid Fortbild Qual Gesundhwes. 2024 Dec;190-191:72-83. German. doi: 10.1016/j.zefq.2024.09.005. Epub 2024 Nov 16. PMID: 39550316.
Roick J, Esser P, Hornemann B, Ernst J.
Control beliefs as mediators between education and quality of life in patients with breast, prostate, colorectal, and lung cancer: a large register based study. BMC Psychol. 2024 Jul 9;12(1):382. doi: 10.1186/s40359-024-01867-7. PMID: 38982524; PMCID: PMC11232264.
Günther M, Schuler M, Hentschel L, Salm H, Schmitz MT, Jaehde U.
Medication Risks and Their Association with Patient-Reported Outcomes in Inpatients with Cancer. Cancers (Basel). 2024 May 31;16(11):2110. doi: 10.3390/cancers16112110. PMID: 38893228; PMCID: PMC11171248.
Eichler M, Hönig K, Bergelt C, Faller H, Maatouk I, Hornemann B, Stein B, Teufel M, Goerling U, Erim Y, Geiser F, Niecke A, Senf B, Weis J.
12-Month Trajectories of Health-Related Quality of Life Following Hospitalization in German Cancer Centers-A Secondary Data Analysis. Curr Oncol. 2024 Apr 23;31(5):2376-2392. doi: 10.3390/curroncol31050177. PMID: 38785458; PMCID: PMC11120277.
2023
Goerling U, Albus C, Bergelt C, Erim Y, Faller H, Geiser F, Hönig K, Hornemann B, Maatouk I, Stein B,
Teufel M, Wickert M, Weis J. Predictors of cancer patients' utilization of psychooncological support: Examining patient´s attitude and physician´s recommendation. J Cancer Res Clin Oncol. 2023 Dec;149(20):17997-18004. doi: 10.1007/s00432-023-05507-2. Epub 2023 Nov 17. PMID: 37978060; PMCID: PMC10725332.
Eichler M, Hentschel L, Singer S, Hornemann B, Richter S, Hofbauer C, Hohenberger P, Kasper B,
Andreou D, Pink D, Jakob J, Grützmann R, Fung S, Wardelmann E, Arndt K, Hermes-Moll K, Schoffer O, Fried M, Jambor HK, Weitz J, Schaser KD, Bornhäuser M, Schmitt J, Schuler MK. Health related Quality of Life over time in German sarcoma patients. An analysis of associated factors - results of the PROSa study. Front Endocrinol (Lausanne). 2023 Aug 29;14:1166838. doi: 0.3389/fendo.2023.1166838. PMID: 37711899; PMCID: PMC10497872.
Salm H, Hentschel L, Eichler M, Pink D, Fuhrmann S, Kramer M, Reichardt P, Schuler MK. Evaluation
of electronic patient-reported outcome assessment in inpatient cancer care: a feasibility study. Support Care Cancer. 2023 Sep 14;31(10):575. doi: 10.1007/s00520-023-08014-9. PMID: 37707633; PMCID: PMC10501936.
Günther M, Hentschel L, Schuler M, Müller T, Schütte K, Ko YD, Schmidt-Wolf I, Jaehde U. Developing
tumor-specific PRO-CTCAE item sets: analysis of a cross- sectional survey in three German outpatient cancer centers. BMC Cancer. 2023 Jul 5;23(1):629. doi: 10.1186/s12885-023-11115-7. PMID: 7407982; PMCID: PMC10320985.
Fugmann D, Richter P, Karger A, Ernstmann N, Hönig K, Bergelt C, Faller H, Maatouk I, Hornemann B,
Stein B, Teufel M, Goerling U, Erim Y, Geiser F, Albus C, Senf B, Wickert M, Weis J. Caring for dependent children impacts practical and emotional problems and need for support, but not perceived distress among cancer patients. Psychooncology. 2023 Aug;32(8):1231-1239. doi: 10.1002/pon.6173. Epub 2023 Jun 5. PMID: 37277899.
Hornemann B, Haering C, Hentschel L, Rentsch A, Taubenheim S, Mehnert- Theuerkauf A, Esser P,
Ernst J. Der Zusammenhang zwischen onkologischen Therapien und wahrgenommener Stigmatisierung bei Krebspatienten mit Brust-, Darm-, Lungen-und Prostatakrebs – Ergebnisse einer registerbasierten Studie [Impact of Oncological Treatment on Perceived Stigmatization - A Register-Based Study]. Psychother Psychosom Med Psychol. 2023 Aug;73(8):328-336. German. doi: 10.1055/a-2003-9523. Epub 2023 Apr 13. PMID: 37054742.
Hofer S, Hentschel L, Richter S, Blum V, Kramer M, Kasper B, Riese C, Schuler MK. Electronic Patient
Reported Outcome (ePRO) Measures in Patients with Soft Tissue Sarcoma (STS) Receiving Palliative Treatment. Cancers (Basel). 2023 Feb 15;15(4):1233. doi: 10.3390/cancers15041233. PMID: 36831574; PMCID: PMC9954494.
2022
Hamacher R, Liu X, Schuler MK, Hentschel L, Schöffski P, Kopp HG, Bauer S, Kasper B, Lindner L,
Chemnitz JM, Crysandt M, Stein A, Steffen B, Richter S, Egerer G, Ivanyi P, Kunitz A, Grünwald V. A post hoc analysis of the EPAZ trial: The role of geriatric variables in elderly soft tissue sarcoma patients on toxicity and outcome. Eur J Cancer. 2023 Mar;181:145-154. doi: 10.1016/j.ejca.2022.12.012. Epub 2022 Dec 27. PMID: 36657323.
Zapata Bonilla SA, Fried M, Singer S, Hentschel L, Richter S, Hohenberger P, Kasper B, Andreou D,
Pink D, Arndt K, Bornhäuser M, Schmitt J, Schuler MK, Eichler M. Working situation and burden of work limitations in sarcoma patients: results from the multi-center prospective PROSa study. J Cancer Res Clin Oncol. 2023 Aug;149(9):6009-6021. doi: 10.1007/s00432-022-04556-3. Epub 2023 Jan 10. PMID: 36624191; PMCID: PMC10356622.
Zimmermann T, Dreismann L, Ginger V, Wenzel M, Hornemann B, Dietzsch F, Sura C, Bornhäuser M,
Mehnert-Theuerkauf A, Heyne S, Gockel I, Lordick F, Franzke A, Weitz J, Vogel A. Study protocol: the OptiScreen-Study: optimized psycho-oncological care-from screening to intervention. J Cancer Res Clin Oncol. 2023 Mar;149(3):1343-1354. doi: 10.1007/s00432-022-04368-5. Epub 2022 Sep 27. PMID: 36166092; PMCID: PMC9514185.
Eichler M, Hentschel L, Singer S, Hornemann B, Hohenberger P, Kasper B, Andreou D, Pink D, Jakob J,
Arndt K, Kirchberg J, Richter S, Bornhäuser M, Schmitt J, Schuler MK. Distress in soft-tissue sarcoma and gastrointestinal stromal tumours patients-Results of a German multicentre observational study (PROSa). Psychooncology. 2022 Oct;31(10):1700-1710. doi: 10.1002/pon.6009. Epub 2022 Aug 18. PMID: 35949152.
Jakob J, Hentschel L, Richter S, Kreisel I, Hohenberger P, Kasper B, Andreou D, Pink D, Schmitt J,
Schuler MK, Eichler M. Transferability of Health-Related Quality of Life Data of Large Observational Studies to Clinical Practice: Comparing Retroperitoneal Sarcoma Patients from the PROSa Study to a TARPS-WG Cohort. Oncol Res Treat. 2022;45(11):660-669. doi: 10.1159/000525288. Epub 2022 Jun 14. PMID: 35700716.
Hentschel L, Wellesen A, Krause LC, von Havranek M, Kramer M, Hornemann B, Bornhäuser M,
Schuler U, Schütte K. Predicting unplanned hospital readmission in palliative outpatients (PRePP) - study protocol of a longitudinal, prospective study to identify informal caregiver-related and structural predictors. BMC Palliat Care. 2022 May 2;21(1):62. doi: 10.1186/s12904-022-00955-y. PMID: 35501763; PMCID: PMC9059677.
Fehm T, Stübs FA, Koch MC, Mallmann P, Dannecker C, Dietl A, Sevnina A, Mergel F, Lotz L; Carolin
C.Hack; Ehret A, Gantert D, Martignoni F, Cieslik JP, Menke J, Ortmann O, Stromberger C, Oechsle K, Hornemann B, Mumm F, […], Beckmann MW. Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May2021) - Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities. Geburtshilfe Frauenheilkd. 2022 Feb 11;82(2):181-205. doi: 10.1055/a-1671-2446. PMID: 35197803; PMCID: PMC8855983.
Eichler M, Singer S, Hentschel L, Richter S, Hohenberger P, Kasper B, Andreou D, Pink D, Jakob J,
Grützmann R, Fung S, Wardelmann E, Arndt K, Heidt V, Bonilla SAZ, Gaidzik VI, Jambor HK, Weitz J, Schaser KD, Bornhäuser M, Schmitt J, Schuler MK. The association of Health-Related Quality of Life and 1-year- survival in sarcoma patients-results of a Nationwide Observational Study (PROSa). Br J Cancer. 2022 May;126(9):1346-1354. doi: 10.1038/s41416-022-01702-z. Epub 2022 Jan 20. PMID: 35058591; PMCID: PMC9042816.
Lieb M, Wünsch A, Schieber K, Bergelt C, Faller H, Geiser F, Goerling U, Hönig K, Hornemann B,
Maatouk I, Niecke A, Stein B, Teufel M, Wickert M, Büttner-Teleagă A, Erim Y, Weis J. Return to work after cancer: Improved mental health in working cancer survivors. Psychooncology. 2022 un;31(6):893-901. doi: 10.1002/pon.5877. Epub 2022 Jan 11. PMID: 34989051.
2021
van Eck I, den Hollander D, Lidington E, Hentschel L, Eichler M, Salah S, Singer S, Pinto M, Fauske L,
Fiore M, Nixon I, Constantinidou A, Desar IME, Bonenkamp JJ, van Houdt WJ, Reuvers MJP, Haas RLM, Bruland ØS, Kasper B, van der Graaf WTA, Husson O. Health-Related Quality of Life Issues Experienced by Thoracic and Breast Sarcoma Patients: A Rare and Understudied Group. J Clin Med. 2021 Nov 16;10(22):5334. doi: 10.3390/jcm10225334. PMID: 34830615; PMCID: PMC8618823.
Eichler M, Pink D, Menge F, Jakob J, Hentschel L, Richter S, Hohenberger P, Kasper B, Andreou D,
Singer S, Grützmann R, Dmytrow DI, Arndt K, Tuchscherer A, Reichardt P, Ahrens M, Kunitz A, Mohm J, Bornhäuser M, Schmitt J, Schuler MK. Quality of life of GIST patients with and without current tyrosine kinase inhibitor treatment: Cross-sectional results of a German multicenter observational study (PROSa). Eur J Cancer Care (Engl). 2021 Nov;30(6):e13484. doi: 10.1111/ecc.13484. Epub 2021 Aug 3. PMID: 34342924.
Lingelbach K, Piechnik D, Gado S, Janssen D, Eichler M, Hentschel L, Knopf D, Schuler M, Sernatinger
D, Peissner M. Effects of the COVID-19 Pandemic on Psychological Well-Being and Mental Health Based on a German Online Survey. Front Public Health. 2021 Jul 8;9:655083. doi: 10.3389/fpubh.2021.655083. PMID: 34307274; PMCID: PMC8296300.
Büttner M, Singer S, Hentschel L, Richter S, Hohenberger P, Kasper B, Andreou D, Pink D, Taylor K,
Arndt K, Bornhäuser M, Schmitt J, Schuler MK, Eichler M. Financial toxicity in sarcoma patients and survivors in Germany: results from the multicenter PROSa study. Support Care Cancer. 2022 Jan;30(1):187-196. doi: 10.1007/s00520-021-06406-3. Epub 2021 Jul 11. PMID: 34247310; PMCID: PMC8636412.
Eichler M, Andreou D, Golcher H, Hentschel L, Richter S, Hohenberger P, Kasper B, Pink D, Jakob J,
Ashmawy H, Hettmer S, Tuchscherer A, Grube M, Heidt V, Jentsch C, Pablik J, Wardelmann E, Kreitner KF, Kneser U, Tonus C, Wimberger P, Schoffer O, Reichardt P, Wartenberg M, Eberlein-Gonska M, Bornhäuser M, Schmitt J, Schuler MK. Utilization of Interdisciplinary Tumor Boards for Sarcoma Care in Germany: Results from the PROSa Study. Oncol Res Treat. 2021;44(6):301-312. doi: 10.1159/000516262. Epub 2021 Apr 22. PMID: 33887740; PMCID: PMC8220922.
Sodergren SC, Wheelwright SJ, Fitzsimmons D, Efficace F, Sprangers M, Fayers P, Harle A, Schmidt H,
Bottomley A, Darlington AS, Benson C, Bredart A, Hentschel L, Arraras JI, Ioannidis G, Leahy M, Lugowska I, Nicolatou-Galitis O, Petranovic D, Rohde GE, Vassiliou V, Johnson CD; EORTC Quality of Life Group. Developing Symptom Lists for People with Cancer Treated with Targeted Therapies. Target Oncol. 2021 Jan;16(1):95-107. doi: 10.1007/s11523-020-00769-z. PMID: 33165751.
2020
den Hollander D, Fiore M, Martin-Broto J, Kasper B, Casado Herraez A, Kulis D, Nixon I, Sodergren SC,
Eichler M, van Houdt WJ, Desar IME, Ray-Coquard I, Piccinin C, Kosela-Paterczyk H, Miah A, Hentschel L, Singer S, Wilson R, van der Graaf WTA, Husson O. Incorporating the Patient Voice in Sarcoma Research: How Can We Assess Health-Related Quality of Life in This Heterogeneous Group of Patients? A Study Protocol. Cancers (Basel). 2020 Dec 22;13(1):1. doi: 10.3390/cancers13010001. PMID: 33561018; PMCID: PMC7792589.
Eichler M, Hentschel L, Richter S, Hohenberger P, Kasper B, Andreou D, Pink D, Jakob J, Singer S,
Grützmann R, Fung S, Wardelmann E, Arndt K, Heidt V, Hofbauer C, Fried M, Gaidzik VI, Verpoort K, Ahrens M, Weitz J, Schaser KD, Bornhäuser M, Schmitt J, Schuler MK, The PROSa Study Group. The Health-Related Quality of Life of Sarcoma Patients and Survivors in Germany-Cross-Sectional Results of a Nationwide Observational Study (PROSa). Cancers (Basel). 2020 Nov 30;12(12):3590. doi: 10.3390/cancers12123590. PMID: 33266287; PMCID: PMC7759994.
Hentschel L, Richter S, Kopp HG, Kasper B, Kunitz A, Grünwald V, Kessler T, Chemnitz JM, Pelzer U,
Schuler U, Freitag J, Schilling A, Hornemann B, Arndt K, Bornhäuser M, Schuler MK. Quality of life and added value of a tailored palliative care intervention in patients with soft tissue sarcoma undergoing treatment with trabectedin: a multicentre, cluster-randomised trial within the German Interdisciplinary Sarcoma Group (GISG). BMJ Open. 2020 Aug 27;10(8):e035546. doi: 10.1136/bmjopen-2019-035546. PMID: 32859662; PMCID: PMC7454199.
2019
Goerling U, Faller H, Hornemann B, Hönig K, Bergelt C, Maatouk I, Stein B, Teufel M, Erim Y, Geiser F,
Niecke A, Senf B, Wickert M, Büttner-Teleaga A, Weis J. Information needs in cancer patients across the disease trajectory. A prospective study. Patient Educ Couns. 2020 Jan;103(1):120-126. doi: 10.1016/j.pec.2019.08.011. Epub 2019 Aug 12. PMID: 31474389.
Sauer C, Weis J, Faller H, Junne F, Hönig K, Bergelt C, Hornemann B, Stein B, Teufel M, Goerling U,
Erim Y, Geiser F, Niecke A, Senf B, Weber D, Maatouk I. Impact of social support on psychosocial symptoms and quality of life in cancer patients: results of a multilevel model approach from a longitudinal multicenter study. Acta Oncol. 2019 Sep;58(9):1298-1306. doi: 10.1080/0284186X.2019.1631471. Epub 2019 Jul 9. PMID: 31284793.
Roick J, Esser P, Hornemann B, Mehnert A, Ernst J. Warum gerade ich? – Subjektive
Krankheitsursachen und Zusammenhänge zu sozialen Faktoren und wahrgenommener Stigmatisierung bei Brust-, Prostata-, Darm- und Lungenkrebspatienten [Why Me? - Causal Attributions and their Relation to Socio- Economic Status and Stigmatization in Breast, Colon, Prostate and Lung Cancer Patients]. Psychother Psychosom Med Psychol. 2020 Jan;70(1):22-31. German. doi: 10.1055/a-0851-6758. Epub 2019 Apr 3. PMID: 30943576.
Benter T, Roehr O, Moser L, Kiewe P, Hentschel L, Platzek I, Schuler MK. Intrasplenic Pancreatic
Pseudocyst after Chemoradiation of a Pancreatic Adenocarcinoma Mimicking Progressive Disease: A Case Report and Review of the Literature. Case Rep Oncol Med. 2019 Feb 14;2019:5808714. doi: 10.1155/2019/5808714. PMID: 30906608; PMCID: PMC6393913.
2018
Weis J, Hönig K, Bergelt C, Faller H, Brechtel A, Hornemann B, Stein B, Teufel M, Goerling U, Erim Y,
Geiser F, Niecke A, Senf B, Wickert M, Schmoor C, Gerlach A, Schellberg D, Büttner-Teleaga A, Schieber K. Psychosocial distress and utilization of professional psychological care in cancer patients: An observational study in National Comprehensive Cancer Centers (CCCs) in Germany. Psychooncology. 2018 Dec;27(12):2847-2854. doi: 10.1002/pon.4901. Epub 2018 Oct 19. PMID: 30276915.
Dittrich R, Kliesch S, […] J, Hoffmann W, Hornemann B, […] Lotz L. Fertility Preservation for Patients
with Malignant Disease. Guideline of the DGGG, DGU and DGRM (S2k-Level, AWMF Registry No. 015/082, November 2017) - Recommendations and Statements for Girls and Women. Geburtshilfe Frauenheilkd. 2018 Jun;78(6):567-584. doi: 10.1055/a-0611-5549. Epub 2018 Jun 25. PMID: 29962516; PMCID: PMC6018069.
2017
Hechtner M, Krause M, König J, Appold S, Hornemann B, Singer S, Baumann M. Long-term quality of
life in inoperable non-small cell lung cancer patients treated with conventionally fractionated compared to hyperfractionated accelerated radiotherapy - Results of the randomized CHARTWEL trial. Radiother Oncol. 2018 Feb;126(2):283-290. doi: 10.1016/j.radonc.2017.12.005. Epub 2017 Dec 19. PMID: 29273262.
Ernst J, Mehnert A, Taubenheim S, Rentsch A, Hornemann B, Esser P. Stigmatisierung von
erwerbstätigen Patienten mit Brust-, Darm-, Prostata- und Lungenkrebs [Stigmatization in Employed Patients with Breast, Intestinal, Prostate and Lung Cancer]. Psychother Psychosom Med Psychol. 2017 Jul;67(7):304-311. German. doi: 10.1055/s-0043-110138. Epub 2017 Jul 18. PMID: 28719922.
Esser P, Mehnert A, Johansen C, Hornemann B, Dietz A, Ernst J. Body image mediates the effect of
cancer-related stigmatization on depression: A new target for intervention. Psychooncology. 2018 Jan;27(1):193-198. doi: 10.1002/pon.4494. Epub 2017 Aug 1. PMID: 28685499.
Schuler M, Richter S, Ehninger G, Bornhäuser M, Hentschel L. A cluster- randomised, controlled
proof-of-concept study to explore the feasibility and effect of a patient-directed intervention on quality of life in patients with advanced soft tissue sarcoma. BMJ Open. 2017 Jun 30;7(6):e014614. doi: 10.1136/bmjopen-2016-014614. PMID: 28667207; PMCID: PMC5734294.
Schuler M, Trautmann F, Radloff M, Hentschel L, Petzold T, Eberlein-Gonska M, Ehninger G, Schmitt J.
Implementation and first results of a tablet-based assessment referring to patient-reported outcomes in an inpatient cancer care unit. Z Evid Fortbild Qual Gesundhwes. 2017 Apr;121:64-72. doi:10.1016/j.zefq.2017.03.007. Epub 2017 Apr 1. PMID: 28372924.
Schuler M, Schildmann J, Trautmann F, Hentschel L, Hornemann B, Rentsch A, Ehninger G, Schmitt J.
Cancer patients' control preferences in decision making and associations with patient-reported outcomes: a prospective study in an outpatient cancer center. Support Care Cancer. 2017 Sep;25(9):2753-2760. doi: 10.1007/s00520-017-3686-8. Epub 2017 Mar 29. PMID: 28357651.
Schuler MK, Hentschel L, Kisel W, Kramer M, Lenz F, Hornemann B, Hoffmann J, Richter S, Ehninger
G, Bornhäuser M, Kroschinsky F. Impact of Different Exercise Programs on Severe Fatigue in Patients Undergoing Anticancer Treatment-A Randomized Controlled Trial. J Pain Symptom Manage. 2017 Jan;53(1):57-66. doi: 10.1016/j.jpainsymman.2016.08.014. Epub 2016 Oct 12. PMID: 27744016.
2016
Wermke M, Schuster C, Nolte F, Al-Ali HK, Kiewe P, Schönefeldt C, Jakob C, von Bonin M, Hentschel L,
Klut IM, Ehninger G, Bornhäuser M, Baretton G, Germing U, Herbst R, Haase D, Hofmann WK, latzbecker U. Mammalian-target of rapamycin inhibition with temsirolimus in myelodysplastic syndromes (MDS) patients is associated with considerable toxicity: results of the temsirolimus pilot trial by the German MDS Study Group (D-MDS). Br J Haematol. 2016 Dec;175(5):917-924. doi: 10.1111/bjh.14345. Epub 2016 Oct 7. PMID: 27714772.
Schuler MK, Gerdes S, West A, Richter S, Busemann C, Hentschel L, Lenz F, Kopp HG, Ehninger G,
Reichardt P, Pink D. Efficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline therapy - a retrospective study including 32 patients. BMC Cancer. 2016 Aug 9;16:619. doi: 10.1186/s12885-016-2654-x. PMID: 27507014; PMCID: PMC4977890.
Schuler MK, Hentschel L, Göbel J, Balaian E, Hornemann B, Hoffmann J, Kramer M, Kasten P,
Bornhäuser M, Ehninger G, Platzbecker U. Effects of a home-based exercise program on physical capacity and fatigue in patients with low to intermediate risk myelodysplastic syndrome-a pilot study. Leuk Res. 2016 Aug;47:128-35. doi: 10.1016/j.leukres.2016.05.022. Epub 2016 May 27. PMID: 27326698.
Hentschel L, Rentsch A, Lenz F, Hornemann B, Schmitt J, Baumann M, Ehninger G, Schuler M. A
Questionnaire Study to Assess the Value of the Vulnerable Elders Survey, G8, and Predictors of Toxicity as Screening Tools for Frailty and Toxicity in Geriatric Cancer Patients. Oncol Res Treat. 2016;39(4):210-6. doi: 10.1159/000445365. Epub 2016 Mar 30. PMID: 27160741.
Schuler MK, Trautmann F, Radloff M, Schmädig R, Hentschel L, Eberlein-Gonska M, Petzold T, Vetter
H, Oberlack S, Ehninger G, Schmitt J. Implementation of a mobile inpatient quality of life (QoL) assessment for oncology nursing. Support Care Cancer. 2016 Aug;24(8):3391-9. doi: 10.1007/s00520-016-3163-9. Epub 2016 Mar 16. PMID: 26984243.
Trautmann F, Hentschel L, Hornemann B, Rentsch A, Baumann M, Ehninger G, Schmitt J, Schuler M.
Electronic real-time assessment of patient-reported outcomes in routine care-first findings and experiences from the implementation in a comprehensive cancer center. Support Care Cancer. 2016 Jul;24(7):3047-56. doi: 10.1007/s00520-016-3127-0. Epub 2016 Feb 18. PMID: 26887586.